Inventor · disambiguated record
Indushekhar Persaud
Also filed as: PERSAUD INDUSHEKHAR
10 granted patents·14 pending applications·184 citations·filing 2005–2024
91Inventor score
Top patents by PatentIndex Score
24 records- 0196US8454945B2Topical formulations having enhanced bioavailabilityMCCOOK JOHN PATRICK·Filed 2008·Granted Jun 4, 2013·95 cites·33 claims
- 0293US8147825B2Topical co-enzyme Q10 formulations and methods of useHSIA SUNG LAN·Filed 2005·Granted Apr 3, 2012·23 cites·19 claims
- 0392US8771680B2Topical co-enzyme Q10 formulations and methods of useUNIV MIAMI·Filed 2013·Granted Jul 8, 2014·12 cites·13 claims
- 0492US8586030B2Co-enzyme Q10 formulations and methods of useUNIV MIAMI·Filed 2013·Granted Nov 19, 2013·12 cites·13 claims
- 0592US8293227B2Topical co-enzyme Q10 formulations and methods of useHSIA SUNG LAN·Filed 2012·Granted Oct 23, 2012·16 cites·10 claims
- 0691US8562976B2Co-enzyme Q10 formulations and methods of useHSIA SUNG LAN·Filed 2012·Granted Oct 22, 2013·12 cites·19 claims
- 0786US10588859B2Topical formulations having enhanced bioavailabilityBERG LLC·Filed 2013·Granted Mar 17, 2020·6 cites·28 claims
- 0884US10583098B2Topical co-enzyme Q10 formulations and treatment of pain, fatigue and woundsHSIA SUNG LAN·Filed 2007·Granted Mar 10, 2020·7 cites·31 claims
- 0981US2023149292A1Co-enzyme q10 formulations and methods of useUNIV MIAMI·Filed 2022·Application pending·0 cites
- 1078US10668028B2Methods and use of inducing apoptosis in cancer cellsBERG LLC·Filed 2015·Granted Jun 2, 2020·1 cites·4 claims
- 1177US2023147697A1Topical formulations having enhanced bioavailabilityBERG LLC·Filed 2022·Application pending·0 cites
- 1276US2011136231A1Methods and use of inducing apoptosis in cancer cellsCYTOTECH LABS LLC·Filed 2009·Application pending·0 cites
- 1373US2021128453A1Co-enzyme q10 formulations and methods of useUNIV MIAMI·Filed 2020·Application pending·0 cites
- 1470US2015010614A1Methods and use of inducing apoptosis in cancer cellsNARAIN NIVEN RAJIN·Filed 2014·Application pending·0 cites
- 1570US2021077424A1Methods and use of inducing apoptosis in cancer cellsBERG LLC·Filed 2020·Application pending·0 cites
- 1668US2025205157A1Topical ruxolitinib foamINCYTE CORP·Filed 2024·Application pending·0 cites
- 1767US2021015748A1Topical formulations having enhanced bioavailabilityBERG LLC·Filed 2020·Application pending·0 cites
- 1866US2024398810A1Topical ruxolitinib foamINCYTE CORP·Filed 2024·Application pending·0 cites
- 1965US2014255372A1Co-enzyme q10 formulations and methods of useUNIV MIAMI·Filed 2014·Application pending·0 cites
- 2064US2012309086A1Methods and use of inducing apoptosis in cancer cellsNARAIN NIVEN RAJIN·Filed 2012·Application pending·0 cites
- 2161US2023190755A1Topical formulations of PI3K-delta inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 2256US2021000761A1Topical co-enzyme q10 formulations and treatment of pain, fatigue and woundsUNIV MIAMI·Filed 2020·Application pending·0 cites
- 2352US10365279B2Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacyNARAIN NIVEN RAJIN·Filed 2009·Granted Jul 30, 2019·0 cites·16 claims
- 2450US2011142914A1Inhalable compositions having enhanced bioavailabilityCYTOTECH LABS LLC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Indushekhar Persaud files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →